Daiwa Securities Group’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-1,400
Closed -$138K – 1015
2017
Q3
$138K Hold
1,400
– – ﹤0.01% 872
2017
Q2
$142K Sell
1,400
-2,700
-66% -$291K ﹤0.01% 865
2017
Q1
$474K Sell
4,100
-700
-15% -$81.4K ﹤0.01% 585
2016
Q4
$576K Buy
4,800
+3,700
+336% +$410K ﹤0.01% 517
2016
Q3
$124K Buy
1,100
+100
+10% +$11.5K ﹤0.01% 782
2016
Q2
$124K Hold
1,000
– – ﹤0.01% 765
2016
Q1
$112K Hold
1,000
– – ﹤0.01% 791
2015
Q4
$109K Hold
1,000
– – ﹤0.01% 799
2015
Q3
$100K Hold
1,000
– – ﹤0.01% 814
2015
Q2
$114K Hold
1,000
– – ﹤0.01% 836
2015
Q1
$104K Hold
1,000
– – ﹤0.01% 792
2014
Q4
$120K Hold
1,000
– – ﹤0.01% 759
2014
Q3
$146K Hold
1,000
– – ﹤0.01% 741
2014
Q2
$167K Hold
1,000
– – ﹤0.01% 712
2014
Q1
$198K Sell
1,000
-100
-9% -$18.9K ﹤0.01% 646
2013
Q4
$210K Hold
1,100
– – ﹤0.01% 638
2013
Q3
$186K Sell
1,100
-100
-8% -$15.5K ﹤0.01% 664
2013
Q2
$182K Buy
+1,200
New +$170K ﹤0.01% 681

Other funds holding CLB

Daiwa Securities Group's CLB Position: Q4 2017 in Review

Daiwa Securities Group sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 1,400 shares — an estimated $138K sold.

Daiwa Securities Group first reported a position in CLB in Q2 2013 and held it in 18 quarters. The position peaked at $576K in Q4 2016. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • Daiwa Securities Group reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • Daiwa Securities Group sold 1,400 Core Laboratories shares in Q4 2017, an estimated $138K.
  • Daiwa Securities Group first reported a position in Core Laboratories in Q2 2013 and held it in 18 quarters.
  • Daiwa Securities Group's Core Laboratories position peaked at $576K in Q4 2016.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Daiwa Securities Group's 13F filing for Q4 2017, filed 6 Feb 2018.